Status:
SUSPENDED
The Predictive Value of Clinical Data on Perioperative and Postoperative Risk Events in Patients With Head and Neck Artery Stenosis
Lead Sponsor:
Tang-Du Hospital
Conditions:
Postoperative Risk Factors for Patients With Carotid Artery Stenosis
Eligibility:
All Genders
18-80 years
Brief Summary
The Predictive Value of Clinical Data on Perioperative and Postoperative Risk Events in Patients With Head and Neck Artery Stenosis
Eligibility Criteria
Inclusion
- (1) All enrolled patients were diagnosed with clear head and neck artery stenosis and a risk event after head and neck revascularization;
- (2) Location of lesion: origin of internal carotid artery, bifurcation of internal and external carotid arteries;
- (3) Patients with symptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, and with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 50% found on angiography;
- (4) Asymptomatic head and neck artery stenosis and risk events after head and neck revascularization, with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 60% found on angiography;
- (5) Asymptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, with a non-invasive examination of stenosis degree less than 70%, but angiography or other examinations indicate that the stenosis lesion is in an unstable state;
- (6) Symptomatic head and neck artery stenosis and risk events after head and neck revascularization, non-invasive examination of head and neck artery stenosis and risk event degree after head and neck revascularization at 50% to 69%
Exclusion
- (1) Patients with poor overall condition and intolerance to general anesthesia;
- (2) Patients with mental illness or severe mental illness;
- (3) Severe respiratory system diseases;
- (4) Pregnant and lactating women;
- (5) Participating in another clinical study;
- (6) Patients with advanced tumors or those who are expected to die within one year;
Key Trial Info
Start Date :
December 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06027463
Start Date
December 1 2022
End Date
December 31 2026
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tangdu Hospital
Xi'an, Shaanxi, China, 710038